Next-Generation Lipids in RNA Interference Therapeutics

ACS Nano

Volumn 11, Issue 8, 2017, Pages 7572-7586

  Rietwyk, Stephanie ^a   Peer, Dan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

cationic lipids; delivery; gene silencing; ionizable amino lipids; lipid nanoparticles; lipidoids; RNA interference; RNAi therapeutics; siRNA; toxicity

Indexed keywords

DISEASES; GENE TRANSFER; GENES; NANOPARTICLES; NUCLEIC ACIDS; RNA; TOXICITY;

CATIONIC LIPIDS; DELIVERY; GENE SILENCING; IONIZABLE AMINO LIPIDS; LIPID NANOPARTICLES; LIPIDOIDS; RNA INTERFERENCE; RNAI THERAPEUTICS; SIRNA;

LIPIDS;

CATION; LIPID; NANOPARTICLE; SMALL INTERFERING RNA;

ANIMAL; CHEMISTRY; GENE SILENCING; GENETICS; HUMAN; PHYSIOLOGY; RNA INTERFERENCE;

ANIMALS; CATIONS; GENE SILENCING; HUMANS; LIPIDS; NANOPARTICLES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 85028513904     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.7b04734     Document Type: Review

References (110)

1. Soutschek, J.; Akinc, A.; Bramlage, B.; Charisse, K.; Constien, R.; Donoghue, M.; Elbashir, S.; Geick, A.; Hadwiger, P.; Harborth, J.; John, M.; Kesavan, V.; Lavine, G.; Pandey, R. K.; Racie, T.; Rajeev, K. G.; Rohl, I.; Toudjarska, I.; Wang, G.; Wuschko, S.; Bumcrot, D.; Koteliansky, V.; Limmer, S.; Manoharan, M.; Vornlocher, H. P. Therapeutic Silencing of an Endogenous Gene by Systemic Administration of Modified siRNAs Nature 2004, 432, 173-178 10.1038/nature03121
2. de Fougerolles, A.; Vornlocher, H. P.; Maraganore, J.; Lieberman, J. Interfering with Disease: A Progress Report on siRNA-Based Therapeutics Nat. Rev. Drug Discovery 2007, 6, 443-453 10.1038/nrd2310
3. Rojanasakul, Y. Antisense Oligonucleotide Therapeutics: Drug Delivery and Targeting Adv. Drug Delivery Rev. 1996, 18, 115-131 10.1016/0169-409X(95)00020-8
4. Akhtar, S.; Kole, R.; Juliano, R. L. Stability of Antisense DNA Oligodeoxynucleotide Analogs in Cellular Extracts and Sera Life Sci. 1991, 49, 1793-1801 10.1016/0024-3205(91)90480-Y
5. Agrawal, S.; Zhang, R. Pharmacokinetics of Oligonucleotides Ciba Found. Symp. 1997, 209, 60-75 discussion 75-68.
6. Vaishnaw, A. K.; Gollob, J.; Gamba-Vitalo, C.; Hutabarat, R.; Sah, D.; Meyers, R.; de Fougerolles, T.; Maraganore, J. A Status Report on RNAi Therapeutics Silence 2010, 1, 14 10.1186/1758-907X-1-14
7. Lv, H.; Zhang, S.; Wang, B.; Cui, S.; Yan, J. Toxicity of Cationic Lipids and Cationic Polymers in Gene Delivery J. Controlled Release 2006, 114, 100-109 10.1016/j.jconrel.2006.04.014
8. Morille, M.; Passirani, C.; Vonarbourg, A.; Clavreul, A.; Benoit, J. P. Progress in Developing Cationic Vectors for Non-Viral Systemic Gene Therapy against Cancer Biomaterials 2008, 29, 3477-3496 10.1016/j.biomaterials.2008.04.036
9. Israelachvili, J. N.; Mitchell, D. J.; Ninham, B. W. Theory of Self-Assembly of Hydrocarbon Amphiphiles into Micelles and Bilayers J. Chem. Soc., Faraday Trans. 2 1976, 72, 1525-1568 10.1039/f29767201525
10. Kaasgaard, T.; Drummond, C. J. Ordered 2-D and 3-D Nanostructured Amphiphile Self-Assembly Materials Stable in Excess Solvent Phys. Chem. Chem. Phys. 2006, 8, 4957-4975 10.1039/b609510k
11. Zhang, J.; Fan, H.; Levorse, D. A.; Crocker, L. S. Interaction of Cholesterol-Conjugated Ionizable Amino Lipids with Biomembranes: Lipid Polymorphism, Structure-Activity Relationship, and Implications for siRNA Delivery Langmuir 2011, 27, 9473-9483 10.1021/la201464k
12. Wasungu, L.; Hoekstra, D. Cationic Lipids, Lipoplexes and Intracellular Delivery of Genes J. Controlled Release 2006, 116, 255-264 10.1016/j.jconrel.2006.06.024
13. Felgner, P. L.; Gadek, T. R.; Holm, M.; Roman, R.; Chan, H. W.; Wenz, M.; Northrop, J. P.; Ringold, G. M.; Danielsen, M. Lipofection: A Highly Efficient, Lipid-Mediated DNA-Transfection Procedure Proc. Natl. Acad. Sci. U. S. A. 1987, 84, 7413-7417 10.1073/pnas.84.21.7413
14. Gao, H.; Hui, K. M. Synthesis of a Novel Series of Cationic Lipids That Can Act as Efficient Gene Delivery Vehicles through Systematic Heterocyclic Substitution of Cholesterol Derivatives Gene Ther. 2001, 8, 855-863 10.1038/sj.gt.3301471
15. Floch, V.; Loisel, S.; Guenin, E.; Herve, A. C.; Clement, J. C.; Yaouanc, J. J. des Abbayes, H. and Ferec, C. Cation Substitution in Cationic Phosphonolipids: A New Concept to Improve Transfection Activity and Decrease Cellular Toxicity J. Med. Chem. 2000, 43, 4617-4628 10.1021/jm000006z
16. Farhood, H.; Gao, X.; Son, K.; Yang, Y. Y.; Lazo, J. S.; Huang, L.; Barsoum, J.; Bottega, R.; Epand, R. M. Cationic Liposomes for Direct Gene Transfer in Therapy of Cancer and Other Diseases Ann. N. Y. Acad. Sci. 1994, 716, 23-34 discussion 34-25. 10.1111/j.1749-6632.1994.tb21701.x
17. Farhood, H.; Bottega, R.; Epand, R. M.; Huang, L. Effect of Cationic Cholesterol Derivatives on Gene Transfer and Protein Kinase C Activity Biochim. Biophys. Acta, Biomembr. 1992, 1111, 239-246 10.1016/0005-2736(92)90316-E
18. Bottega, R.; Epand, R. M. Inhibition of Protein Kinase C by Cationic Amphiphiles Biochemistry 1992, 31, 9025-9030 10.1021/bi00152a045
19. Solodin, I.; Brown, C. S.; Bruno, M. S.; Chow, C.-Y.; Jang, E.-H.; Debs, R. J.; Heath, T. D. A Novel Series of Amphiphilic Imidazolinium Compounds for In Vitro and In Vivo Gene Delivery Biochemistry 1995, 34, 13537-13544 10.1021/bi00041a033
20. Ilies, M. A.; Johnson, B. H.; Makori, F.; Miller, A.; Seitz, W. A.; Thompson, E. B.; Balaban, A. T. Pyridinium Cationic Lipids in Gene Delivery: An In Vitro and In Vivo Comparison of Transfection Efficiency Versus a Tetraalkylammonium Congener Arch. Biochem. Biophys. 2005, 435, 217-226 10.1016/j.abb.2004.12.010
21. van der Woude, I.; Wagenaar, A.; Meekel, A. A.; ter Beest, M. B.; Ruiters, M. H.; Engberts, J. B.; Hoekstra, D. Novel Pyridinium Surfactants for Efficient, Nontoxic In Vitro Gene Delivery Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 1160-1165 10.1073/pnas.94.4.1160
22. Yingyongnarongkul, B. E.; Howarth, M.; Elliott, T.; Bradley, M. Solid-Phase Synthesis of 89 Polyamine-Based Cationic Lipids for DNA Delivery to Mammalian Cells Chem.-Eur. J. 2004, 10, 463-473 10.1002/chem.200305232
23. Floch, V.; Audrezet, M. P.; Guillaume, C.; Gobin, E.; Le Bolch, G.; Clement, J. C.; Yaouanc, J. J.; Des Abbayes, H.; Mercier, B.; Leroy, J. P.; Abgrall, J. F.; Ferec, C. Transgene Expression Kinetics after Transfection with Cationic Phosphonolipids in Hematopoietic Non Adherent Cells Biochim. Biophys. Acta, Biomembr. 1998, 1371, 53-70 10.1016/S0005-2736(98)00002-9
24. Felgner, J. H.; Kumar, R.; Sridhar, C. N.; Wheeler, C. J.; Tsai, Y. J.; Border, R.; Ramsey, P.; Martin, M.; Felgner, P. L. Enhanced Gene Delivery and Mechanism Studies with a Novel Series of Cationic Lipid Formulations J. Biol. Chem. 1994, 269, 2550-2561
25. Heyes, J. A.; Niculescu-Duvaz, D.; Cooper, R. G.; Springer, C. J. Synthesis of Novel Cationic Lipids: Effect of Structural Modification on the Efficiency of Gene Transfer J. Med. Chem. 2002, 45, 99-114 10.1021/jm010918g
26. Tang, F.; Hughes, J. A. Synthesis of a Single-Tailed Cationic Lipid and Investigation of Its Transfection J. Controlled Release 1999, 62, 345-358 10.1016/S0168-3659(99)00158-3
27. Jones, C. H.; Chen, C. K.; Ravikrishnan, A.; Rane, S.; Pfeifer, B. A. Overcoming Nonviral Gene Delivery Barriers: Perspective and Future Mol. Pharmaceutics 2013, 10, 4082-4098 10.1021/mp400467x
28. Lin, P. J.; Tam, Y. Y.; Hafez, I.; Sandhu, A.; Chen, S.; Ciufolini, M. A.; Nabi, I. R.; Cullis, P. R. Influence of Cationic Lipid Composition on Uptake and Intracellular Processing of Lipid Nanoparticle Formulations of siRNA Nanomedicine 2013, 9, 233-246 10.1016/j.nano.2012.05.019
29. Liu, D.; Hu, J.; Qiao, W.; Li, Z.; Zhang, S.; Cheng, L. Synthesis of Carbamate-Linked Lipids for Gene Delivery Bioorg. Med. Chem. Lett. 2005, 15, 3147-3150 10.1016/j.bmcl.2005.04.010
30. Liu, D.; Hu, i.; Qiao, W.; Li, Z.; Zhan, S.; Cheng, L. Synthesis and Characterization of a Series of Carbamate-Linked Cationic Lipids for Gene Delivery Lipids 2005, 40, 839-848 10.1007/s11745-005-1446-5
31. Wagner, R. W.; Matteucci, M. D.; Lewis, J. G.; Gutierrez, A. J.; Moulds, C.; Froehler, B. C. Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines Science 1993, 260, 1510-1513 10.1126/science.7684856
32. Bennett, C. F.; Chiang, M. Y.; Chan, H.; Shoemaker, J. E.; Mirabelli, C. K. Cationic Lipids Enhance Cellular Uptake and Activity of Phosphorothioate Antisense Oligonucleotides Mol. Pharmacol. 1992, 41, 1023-1033
33. Stewart, M. J.; Plautz, G. E.; Del Buono, L.; Yang, Z. Y.; Xu, L.; Gao, X.; Huang, L.; Nabel, E. G.; Nabel, G. J. Gene Transfer In Vivo with DNA-Liposome Complexes: Safety and Acute Toxicity in Mice Hum. Gene Ther. 1992, 3, 267-275 10.1089/hum.1992.3.3-267
34. Ropert, C.; Lavignon, M.; Dubernet, C.; Couvreur, P.; Malvy, C. Oligonucleotides Encapsulated in pH Sensitive Liposomes Are Efficient toward Friend Retrovirus Biochem. Biophys. Res. Commun. 1992, 183, 879-885 10.1016/0006-291X(92)90565-3
35. Landesman-Milo, D.; Peer, D. Toxicity Profiling of Several Common RNAi-Based Nanomedicines: A Comparative Study Drug Delivery Transl. Res. 2014, 4, 96-103 10.1007/s13346-013-0158-7
36. Peer, D. Immunotoxicity Derived from Manipulating Leukocytes with Lipid-Based Nanoparticles Adv. Drug Delivery Rev. 2012, 64, 1738-1748 10.1016/j.addr.2012.06.013
37. Kircheis, R.; Schuller, S.; Brunner, S.; Ogris, M.; Heider, K. H.; Zauner, W.; Wagner, E. Polycation-Based DNA Complexes for Tumor-Targeted Gene Delivery In Vivo J. Gene Med. 1999, 1, 111-120 10.1002/(SICI)1521-2254(199903/04)1:2<111::AID-JGM22>3.3.CO;2-P
38. Kedmi, R.; Ben-Arie, N.; Peer, D. The Systemic Toxicity of Positively Charged Lipid Nanoparticles and the Role of Toll-Like Receptor 4 in Immune Activation Biomaterials 2010, 31, 6867-6875 10.1016/j.biomaterials.2010.05.027
39. Litzinger, D. C. Limitations of Cationic Liposomes for Antisense Oligonucleotide Delivery J. Liposome Res. 1997, 7, 51-61 10.3109/08982109709035481
40. Lappalainen, K.; Jaaskelainen, I.; Syrjanen, K.; Urtti, A.; Syrjanen, S. Comparison of Cell Proliferation and Toxicity Assays Using Two Cationic Liposomes Pharm. Res. 1994, 11, 1127-1131 10.1023/A:1018932714745
41. Zhang, J.-S.; Liu, F.; Huang, L. Implications of Pharmacokinetic Behavior of Lipoplex for Its Inflammatory Toxicity Adv. Drug Delivery Rev. 2005, 57, 689-698 10.1016/j.addr.2004.12.004
42. McLean, J. W.; Fox, E. A.; Baluk, P.; Bolton, P. B.; Haskell, A.; Pearlman, R.; Thurston, G.; Umemoto, E. Y.; McDonald, D. M. Organ-Specific Endothelial Cell Uptake of Cationic Liposome-DNA Complexes in Mice Am. J. Physiol. Heart Circ. Physiol. 1997, 273, H387-H404
43. Mahato, R. I.; Kawabata, K.; Takakura, Y.; Hashida, M. In Vivo Disposition Characteristics of Plasmid DNA Complexed with Cationic Liposomes J. Drug Target 1995, 3, 149-157 10.3109/10611869509059214
44. Semple, S. C.; Klimuk, S. K.; Harasym, T. O.; Dos Santos, N.; Ansell, S. M.; Wong, K. F.; Maurer, N.; Stark, H.; Cullis, P. R.; Hope, M. J.; Scherrer, P. Efficient Encapsulation of Antisense Oligonucleotides in Lipid Vesicles Using Ionizable Aminolipids: Formation of Novel Small Multilamellar Vesicle Structures Biochim. Biophys. Acta, Biomembr. 2001, 1510, 152-166 10.1016/S0005-2736(00)00343-6
45. Jayaraman, M.; Ansell, S. M.; Mui, B. L.; Tam, Y. K.; Chen, J.; Du, X.; Butler, D.; Eltepu, L.; Matsuda, S.; Narayanannair, J. K.; Rajeev, K. G.; Hafez, I. M.; Akinc, A.; Maier, M. A.; Tracy, M. A.; Cullis, P. R.; Madden, T. D.; Manoharan, M.; Hope, M. J. Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo Angew. Chem., Int. Ed. 2012, 51, 8529-8533 10.1002/anie.201203263
46. Bhattacharya, S.; Mandal, S. S. Evidence of Interlipidic Ion-Pairing in Anion-Induced DNA Release from Cationic Amphiphile-DNA Complexes. Mechanistic Implications in Transfection Biochemistry 1998, 37, 7764-7777 10.1021/bi971772j
47. Kanasty, R.; Dorkin, J. R.; Vegas, A.; Anderson, D. Delivery Materials for siRNA Therapeutics Nat. Mater. 2013, 12, 967-977 10.1038/nmat3765
48. Heyes, J.; Palmer, L.; Bremner, K.; MacLachlan, I. Cationic Lipid Saturation Influences Intracellular Delivery of Encapsulated Nucleic Acids J. Controlled Release 2005, 107, 276-287 10.1016/j.jconrel.2005.06.014
49. Semple, S. C.; Akinc, A.; Chen, J.; Sandhu, A. P.; Mui, B. L.; Cho, C. K.; Sah, D. W. Y.; Stebbing, D.; Crosley, E. J.; Yaworski, E.; Hafez, I. M.; Dorkin, J. R.; Qin, J.; Lam, K.; Rajeev, K. G.; Wong, K. F.; Jeffs, L. B.; Nechev, L.; Eisenhardt, M. L.; Jayaraman, M.; Kazem, M.; Maier, M. A.; Srinivasulu, M.; Weinstein, M. J.; Chen, Q.; Alvarez, R.; Barros, S. A.; De, S.; Klimuk, S. K.; Borland, T.; Kosovrasti, V.; Cantley, W. L.; Tam, Y. K.; Manoharan, M.; Ciufolini, M. A.; Tracy, M. A.; de Fougerolles, A.; MacLachlan, I.; Cullis, P. R.; Madden, T. D.; Hope, M. J. Rational Design of Cationic Lipids for siRNA Delivery Nat. Biotechnol. 2010, 28, 172-176 10.1038/nbt.1602
50. Alabi, C. A.; Love, K. T.; Sahay, G.; Yin, H.; Luly, K. M.; Langer, R.; Anderson, D. G. Multiparametric Approach for the Evaluation of Lipid Nanoparticles for siRNA Delivery Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 12881-12886 10.1073/pnas.1306529110
51. Maier, M. A.; Jayaraman, M.; Matsuda, S.; Liu, J.; Barros, S.; Querbes, W.; Tam, Y. K.; Ansell, S. M.; Kumar, V.; Qin, J.; Zhang, X.; Wang, Q.; Panesar, S.; Hutabarat, R.; Carioto, M.; Hettinger, J.; Kandasamy, P.; Butler, D.; Rajeev, K. G.; Pang, B.; Charisse, K.; Fitzgerald, K.; Mui, B. L.; Du, X.; Cullis, P.; Madden, T. D.; Hope, M. J.; Manoharan, M.; Akinc, A. Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics Mol. Ther. 2013, 21, 1570-1578 10.1038/mt.2013.124
52. Yanagi, T.; Tachikawa, K.; Wilkie-Grantham, R.; Hishiki, A.; Nagai, K.; Toyonaga, E.; Chivukula, P.; Matsuzawa, S. Lipid Nanoparticle-Mediated siRNA Transfer against PCTAIRE1/PCTK1/CDK16 Inhibits In Vivo Cancer Growth Mol. Ther. - Nucleic Acids 2016, 5, e327 10.1038/mtna.2016.40
53. Ramaswamy, S.; Tonnu, N.; Tachikawa, K.; Limphong, P.; Vega, J. B.; Karmali, P. P.; Chivukula, P.; Verma, I. M. Systemic Delivery of Factor IX Messenger RNA for Protein Replacement Therapy Proc. Natl. Acad. Sci. U. S. A. 2017, 114, E1941-E1950 10.1073/pnas.1619653114
54. Suzuki, Y.; Hyodo, K.; Suzuki, T.; Tanaka, Y.; Kikuchi, H.; Ishihara, H. Biodegradable Lipid Nanoparticles Induce a Prolonged RNA Interference-Mediated Protein Knockdown and Show Rapid Hepatic Clearance in Mice and Nonhuman Primates Int. J. Pharm. 2017, 519, 34-43 10.1016/j.ijpharm.2017.01.016
55. Zelphati, O.; Szoka, F. C., Jr. Mechanism of Oligonucleotide Release from Cationic Liposomes Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 11493-11498 10.1073/pnas.93.21.11493
56. Zabner, J.; Fasbender, A. J.; Moninger, T.; Poellinger, K. A.; Welsh, M. J. Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid J. Biol. Chem. 1995, 270, 18997-19007 10.1074/jbc.270.32.18997
57. Stegmann, T.; Legendre, J. Y. Gene Transfer Mediated by Cationic Lipids: Lack of a Correlation between Lipid Mixing and Transfection Biochim. Biophys. Acta, Biomembr. 1997, 1325, 71-79 10.1016/S0005-2736(96)00241-6
58. Mui, B.; Ahkong, Q. F.; Chow, L.; Hope, M. J. Membrane Perturbation and the Mechanism of Lipid-Mediated Transfer of DNA into Cells Biochim. Biophys. Acta, Biomembr. 2000, 1467, 281-292 10.1016/S0005-2736(00)00226-1
59. Hafez, I. M.; Maurer, N.; Cullis, P. R. On the Mechanism Whereby Cationic Lipids Promote Intracellular Delivery of Polynucleic Acids Gene Ther. 2001, 8, 1188-1196 10.1038/sj.gt.3301506
60. Adami, R. C.; Seth, S.; Harvie, P.; Johns, R.; Fam, R.; Fosnaugh, K.; Zhu, T.; Farber, K.; McCutcheon, M.; Goodman, T. T.; Liu, Y.; Chen, Y.; Kwang, E.; Templin, M. V.; Severson, G.; Brown, T.; Vaish, N.; Chen, F.; Charmley, P.; Polisky, B.; Houston, M. E., Jr. An Amino Acid-Based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA Mol. Ther. 2011, 19, 1141-1151 10.1038/mt.2011.56
61. Zuhorn, I. S.; Bakowsky, U.; Polushkin, E.; Visser, W. H.; Stuart, M. C.; Engberts, J. B.; Hoekstra, D. Nonbilayer Phase of Lipoplex-Membrane Mixture Determines Endosomal Escape of Genetic Cargo and Transfection Efficiency Mol. Ther. 2005, 11, 801-810 10.1016/j.ymthe.2004.12.018
62. Song, L. Y.; Ahkong, Q. F.; Rong, Q.; Wang, Z.; Ansell, S.; Hope, M. J.; Mui, B. Characterization of the Inhibitory Effect of PEG-Lipid Conjugates on the Intracellular Delivery of Plasmid and Antisense DNA Mediated by Cationic Lipid Liposomes Biochim. Biophys. Acta, Biomembr. 2002, 1558, 1-13 10.1016/S0005-2736(01)00399-6
63. Rehman, Z.u.; Zuhorn, I. S.; Hoekstra, D. How Cationic Lipids Transfer Nucleic Acids into Cells and across Cellular Membranes: Recent Advances J. Controlled Release 2013, 166, 46-56 10.1016/j.jconrel.2012.12.014
64. Walsh, C. L.; Nguyen, J.; Tiffany, M. R.; Szoka, F. C. Synthesis, Characterization, and Evaluation of Ionizable Lysine-Based Lipids for siRNA Delivery Bioconjugate Chem. 2013, 24, 36-43 10.1021/bc300346h
65. Leung, A. K. K.; Hafez, I. M.; Baoukina, S.; Belliveau, N. M.; Zhigaltsev, I. V.; Afshinmanesh, E.; Tieleman, D. P.; Hansen, C. L.; Hope, M. J.; Cullis, P. R. Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core J. Phys. Chem. C 2012, 116, 18440-18450 10.1021/jp303267y
66. Morrissey, D. V.; Lockridge, J. A.; Shaw, L.; Blanchard, K.; Jensen, K.; Breen, W.; Hartsough, K.; Machemer, L.; Radka, S.; Jadhav, V.; Vaish, N.; Zinnen, S.; Vargeese, C.; Bowman, K.; Shaffer, C. S.; Jeffs, L. B.; Judge, A.; MacLachlan, I.; Polisky, B. Potent and Persistent In Vivo Anti-HBV Activity of Chemically Modified siRNAs Nat. Biotechnol. 2005, 23, 1002-1007 10.1038/nbt1122
67. Zimmermann, T. S.; Lee, A. C. H.; Akinc, A.; Bramlage, B.; Bumcrot, D.; Fedoruk, M. N.; Harborth, J.; Heyes, J. A.; Jeffs, L. B.; John, M.; Judge, A. D.; Lam, K.; McClintock, K.; Nechev, L. V.; Palmer, L. R.; Racie, T.; Röhl, I.; Seiffert, S.; Shanmugam, S.; Sood, V.; Soutschek, J.; Toudjarska, I.; Wheat, A. J.; Yaworski, E.; Zedalis, W.; Koteliansky, V.; Manoharan, M.; Vornlocher, H.-P.; MacLachlan, I. RNAi-Mediated Gene Silencing in Non-Human Primates Nature 2006, 441, 111-114 10.1038/nature04688
68. Akinc, A.; Zumbuehl, A.; Goldberg, M.; Leshchiner, E. S.; Busini, V.; Hossain, N.; Bacallado, S. A.; Nguyen, D. N.; Fuller, J.; Alvarez, R.; Borodovsky, A.; Borland, T.; Constien, R.; de Fougerolles, A.; Dorkin, J. R.; Narayanannair Jayaprakash, K.; Jayaraman, M.; John, M.; Koteliansky, V.; Manoharan, M.; Nechev, L.; Qin, J.; Racie, T.; Raitcheva, D.; Rajeev, K. G.; Sah, D. W. Y.; Soutschek, J.; Toudjarska, I.; Vornlocher, H.-P.; Zimmermann, T. S.; Langer, R.; Anderson, D. G. A Combinatorial Library of Lipid-Like Materials for Delivery of RNAi Therapeutics Nat. Biotechnol. 2008, 26, 561-569 10.1038/nbt1402
69. Love, K. T.; Mahon, K. P.; Levins, C. G.; Whitehead, K. A.; Querbes, W.; Dorkin, J. R.; Qin, J.; Cantley, W.; Qin, L. L.; Racie, T.; Frank-Kamenetsky, M.; Yip, K. N.; Alvarez, R.; Sah, D. W. Y.; de Fougerolles, A.; Fitzgerald, K.; Koteliansky, V.; Akinc, A.; Langer, R.; Anderson, D. G. Lipid-Like Materials for Low-Dose, In Vivo Gene Silencing Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 1864-1869 10.1073/pnas.0910603106
70. Ball, R. L.; Knapp, C. M.; Whitehead, K. A. Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model PLoS One 2015, 10, e0133154 10.1371/journal.pone.0133154
71. Knapp, C. M.; Guo, P.; Whitehead, K. A. Lipidoid Tail Structure Strongly Influences siRNA Delivery Activity Cell. Mol. Bioeng. 2016, 9, 305-314 10.1007/s12195-016-0436-9
72. Whitehead, K. A.; Dorkin, J. R.; Vegas, A. J.; Chang, P. H.; Veiseh, O.; Matthews, J.; Fenton, O. S.; Zhang, Y.; Olejnik, K. T.; Yesilyurt, V.; Chen, D.; Barros, S.; Klebanov, B.; Novobrantseva, T.; Langer, R.; Anderson, D. G. Degradable Lipid Nanoparticles with Predictable In Vivo siRNA Delivery Activity Nat. Commun. 2014, 5, 4277 10.1038/ncomms5277
73. Knapp, C. M.; He, J.; Lister, J.; Whitehead, K. A. Lipidoid Nanoparticle Mediated Silencing of Mcl-1 Induces Apoptosis in Mantle Cell Lymphoma Exp. Biol. Med. (London, U. K.) 2016, 241, 1007-1013 10.1177/1535370216640944
74. Sahay, G.; Querbes, W.; Alabi, C.; Eltoukhy, A.; Sarkar, S.; Zurenko, C.; Karagiannis, E.; Love, K.; Chen, D.; Zoncu, R.; Buganim, Y.; Schroeder, A.; Langer, R.; Anderson, D. G. Efficiency of siRNA Delivery by Lipid Nanoparticles Is Limited by Endocytic Recycling Nat. Biotechnol. 2013, 31, 653-658 10.1038/nbt.2614
75. Gilleron, J.; Querbes, W.; Zeigerer, A.; Borodovsky, A.; Marsico, G.; Schubert, U.; Manygoats, K.; Seifert, S.; Andree, C.; Stoter, M.; Epstein-Barash, H.; Zhang, L.; Koteliansky, V.; Fitzgerald, K.; Fava, E.; Bickle, M.; Kalaidzidis, Y.; Akinc, A.; Maier, M.; Zerial, M. Image-Based Analysis of Lipid Nanoparticle-Mediated siRNA Delivery, Intracellular Trafficking and Endosomal Escape Nat. Biotechnol. 2013, 31, 638-646 10.1038/nbt.2612
76. Wang, H.; Tam, Y. Y. C.; Chen, S.; Zaifman, J.; van der Meel, R.; Ciufolini, M. A.; Cullis, P. R. The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA Mol. Ther. 2016, 24, 2100-2108 10.1038/mt.2016.179
77. Wang, Y.; Huang, L. A Window onto siRNA Delivery Nat. Biotechnol. 2013, 31, 611-612 10.1038/nbt.2634
78. Leuschner, F.; Dutta, P.; Gorbatov, R.; Novobrantseva, T. I.; Donahoe, J. S.; Courties, G.; Lee, K. M.; Kim, J. I.; Markmann, J. F.; Marinelli, B.; Panizzi, P.; Lee, W. W.; Iwamoto, Y.; Milstein, S.; Epstein-Barash, H.; Cantley, W.; Wong, J.; Cortez-Retamozo, V.; Newton, A.; Love, K.; Libby, P.; Pittet, M. J.; Swirski, F. K.; Koteliansky, V.; Langer, R.; Weissleder, R.; Anderson, D. G.; Nahrendorf, M. Therapeutic siRNA Silencing in Inflammatory Monocytes in Mice Nat. Biotechnol. 2011, 29, 1005-1010 10.1038/nbt.1989
79. Majmudar, M. D.; Keliher, E. J.; Heidt, T.; Leuschner, F.; Truelove, J.; Sena, B. F.; Gorbatov, R.; Iwamoto, Y.; Dutta, P.; Wojtkiewicz, G.; Courties, G.; Sebas, M.; Borodovsky, A.; Fitzgerald, K.; Nolte, M. W.; Dickneite, G.; Chen, J. W.; Anderson, D. G.; Swirski, F. K.; Weissleder, R.; Nahrendorf, M. Monocyte-Directed RNAi Targeting CCR2 Improves Infarct Healing in Atherosclerosis-Prone Mice Circulation 2013, 127, 2038-2046 10.1161/CIRCULATIONAHA.112.000116
80. Sager, H. B.; Dutta, P.; Dahlman, J. E.; Hulsmans, M.; Courties, G.; Sun, Y.; Heidt, T.; Vinegoni, C.; Borodovsky, A.; Fitzgerald, K.; Wojtkiewicz, G. R.; Iwamoto, Y.; Tricot, B.; Khan, O. F.; Kauffman, K. J.; Xing, Y.; Shaw, T. E.; Libby, P.; Langer, R.; Weissleder, R.; Swirski, F. K.; Anderson, D. G.; Nahrendorf, M. RNAi Targeting Multiple Cell Adhesion Molecules Reduces Immune Cell Recruitment and Vascular Inflammation after Myocardial Infarction Sci. Transl. Med. 2016, 8, 342ra80 10.1126/scitranslmed.aaf1435
81. Courties, G.; Heidt, T.; Sebas, M.; Iwamoto, Y.; Jeon, D.; Truelove, J.; Tricot, B.; Wojtkiewicz, G.; Dutta, P.; Sager, H. B.; Borodovsky, A.; Novobrantseva, T.; Klebanov, B.; Fitzgerald, K.; Anderson, D. G.; Libby, P.; Swirski, F. K.; Weissleder, R.; Nahrendorf, M. In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing J. Am. Coll. Cardiol. 2014, 63, 1556-1566 10.1016/j.jacc.2013.11.023
82. Novobrantseva, T. I.; Borodovsky, A.; Wong, J.; Klebanov, B.; Zafari, M.; Yucius, K.; Querbes, W.; Ge, P.; Ruda, V. M.; Milstein, S.; Speciner, L.; Duncan, R.; Barros, S.; Basha, G.; Cullis, P.; Akinc, A.; Donahoe, J. S.; Narayanannair Jayaprakash, K.; Jayaraman, M.; Bogorad, R. L.; Love, K.; Whitehead, K.; Levins, C.; Manoharan, M.; Swirski, F. K.; Weissleder, R.; Langer, R.; Anderson, D. G.; de Fougerolles, A.; Nahrendorf, M.; Koteliansky, V. Systemic RNAi-Mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells Mol. Ther. - Nucleic Acids 2012, 1, e4 10.1038/mtna.2011.3
83. Basha, G.; Ordobadi, M.; Scott, W. R.; Cottle, A.; Liu, Y.; Wang, H.; Cullis, P. R. Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin Mol. Ther. - Nucleic Acids 2016, 5, e363 10.1038/mtna.2016.68
84. Xu, C.-f.; Wang, J. Delivery Systems for siRNA Drug Development in Cancer Therapy Asian J. Pharm. Sci. 2015, 10, 1-12 10.1016/j.ajps.2014.08.011
85. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760 10.1038/nnano.2007.387
86. Bartlett, D. W.; Su, H.; Hildebrandt, I. J.; Weber, W. A.; Davis, M. E. Impact of Tumor-Specific Targeting on the Biodistribution and Efficacy of siRNA Nanoparticles Measured by Multimodality In Vivo Imaging Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 15549-15554 10.1073/pnas.0707461104
87. Li, S. D.; Huang, L. Pharmacokinetics and Biodistribution of Nanoparticles Mol. Pharmaceutics 2008, 5, 496-504 10.1021/mp800049w
88. Ernsting, M. J.; Murakami, M.; Roy, A.; Li, S.-D. Factors Controlling the Pharmacokinetics, Biodistribution and Intratumoral Penetration of Nanoparticles J. Controlled Release 2013, 172, 782-794 10.1016/j.jconrel.2013.09.013
89. Kirpotin, D. B.; Drummond, D. C.; Shao, Y.; Shalaby, M. R.; Hong, K.; Nielsen, U. B.; Marks, J. D.; Benz, C. C.; Park, J. W. Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models Cancer Res. 2006, 66, 6732-6740 10.1158/0008-5472.CAN-05-4199
90. Reuter, K. G.; Perry, J. L.; Kim, D.; Luft, J. C.; Liu, R.; DeSimone, J. M. Targeted Print Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation Nano Lett. 2015, 15, 6371-6378 10.1021/acs.nanolett.5b01362
91. Renneisen, K.; Leserman, L.; Matthes, E.; Schroder, H. C.; Muller, W. E. Inhibition of Expression of Human Immunodeficiency Virus-1 In Vitro by Antibody-Targeted Liposomes Containing Antisense RNA to the Env Region J. Biol. Chem. 1990, 265, 16337-16342
92. Kim, S. S.; Peer, D.; Kumar, P.; Subramanya, S.; Wu, H.; Asthana, D.; Habiro, K.; Yang, Y. G.; Manjunath, N.; Shimaoka, M.; Shankar, P. RNAi-Mediated CCR5 Silencing by LFA-1-Targeted Nanoparticles Prevents HIV Infection in BLT Mice Mol. Ther. 2010, 18, 370-376 10.1038/mt.2009.271
93. Ramishetti, S.; Kedmi, R.; Goldsmith, M.; Leonard, F.; Sprague, A. G.; Godin, B.; Gozin, M.; Cullis, P. R.; Dykxhoorn, D. M.; Peer, D. Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles ACS Nano 2015, 9, 6706-6716 10.1021/acsnano.5b02796
94. Weinstein, S.; Toker, I. A.; Emmanuel, R.; Ramishetti, S.; Hazan-Halevy, I.; Rosenblum, D.; Goldsmith, M.; Abraham, A.; Benjamini, O.; Bairey, O.; Raanani, P.; Nagler, A.; Lieberman, J.; Peer, D. Harnessing RNAi-Based Nanomedicines for Therapeutic Gene Silencing in B-Cell Malignancies Proc. Natl. Acad. Sci. U. S. A. 2016, 113, E16-22 10.1073/pnas.1519273113
95. Cohen, Z. R.; Ramishetti, S.; Peshes-Yaloz, N.; Goldsmith, M.; Wohl, A.; Zibly, Z.; Peer, D. Localized RNAi Therapeutics of Chemoresistant Grade IV Glioma Using Hyaluronan-Grafted Lipid-Based Nanoparticles ACS Nano 2015, 9, 1581-1591 10.1021/nn506248s
96. Peer, D.; Park, E. J.; Morishita, Y.; Carman, C. V.; Shimaoka, M. Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory Target Science 2008, 319, 627-630 10.1126/science.1149859
97. Akinc, A.; Querbes, W.; De, S.; Qin, J.; Frank-Kamenetsky, M.; Jayaprakash, K. N.; Jayaraman, M.; Rajeev, K. G.; Cantley, W. L.; Dorkin, J. R.; Butler, J. S.; Qin, L.; Racie, T.; Sprague, A.; Fava, E.; Zeigerer, A.; Hope, M. J.; Zerial, M.; Sah, D. W.; Fitzgerald, K.; Tracy, M. A.; Manoharan, M.; Koteliansky, V.; Fougerolles, A.; Maier, M. A. Targeted Delivery of RNAi Therapeutics with Endogenous and Exogenous Ligand-Based Mechanisms Mol. Ther. 2010, 18, 1357-1364 10.1038/mt.2010.85
98. Yoshizawa, T.; Hattori, Y.; Hakoshima, M.; Koga, K.; Maitani, Y. Folate-Linked Lipid-Based Nanoparticles for Synthetic siRNA Delivery in KB Tumor Xenografts Eur. J. Pharm. Biopharm. 2008, 70, 718-725 10.1016/j.ejpb.2008.06.026
99. Gottschalk, S.; Cristiano, R. J.; Smith, L. C.; Woo, S. L. Folate Receptor Mediated DNA Delivery into Tumor Cells: Potosomal Disruption Results in Enhanced Gene Expression Gene Ther. 1994, 1, 185-191
100. Gindy, M. E.; Leone, A. M.; Cunningham, J. J. Challenges in the Pharmaceutical Development of Lipid-Based Short Interfering Ribonucleic Acid Therapeutics Expert Opin. Drug Delivery 2012, 9, 171-182 10.1517/17425247.2012.642363
101. Valencia, P. M.; Farokhzad, O. C.; Karnik, R.; Langer, R. Microfluidic Technologies for Accelerating the Clinical Translation of Nanoparticles Nat. Nanotechnol. 2012, 7, 623-629 10.1038/nnano.2012.168
102. Abrams, M. T.; Koser, M. L.; Seitzer, J.; Williams, S. C.; DiPietro, M. A.; Wang, W.; Shaw, A. W.; Mao, X.; Jadhav, V.; Davide, J. P.; Burke, P. A.; Sachs, A. B.; Stirdivant, S. M.; Sepp-Lorenzino, L. Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-Treatment Mol. Ther. 2010, 18, 171-180 10.1038/mt.2009.208
103. Belliveau, N. M.; Huft, J.; Lin, P. J.; Chen, S.; Leung, A. K.; Leaver, T. J.; Wild, A. W.; Lee, J. B.; Taylor, R. J.; Tam, Y. K.; Hansen, C. L.; Cullis, P. R. Microfluidic Synthesis of Highly Potent Limit-Size Lipid Nanoparticles for In Vivo Delivery of siRNA Mol. Ther. - Nucleic Acids 2012, 1, e37 10.1038/mtna.2012.28
104. Chen, D.; Love, K. T.; Chen, Y.; Eltoukhy, A. A.; Kastrup, C.; Sahay, G.; Jeon, A.; Dong, Y.; Whitehead, K. A.; Anderson, D. G. Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation J. Am. Chem. Soc. 2012, 134, 6948-6951 10.1021/ja301621z
105. Leung, A. K. K.; Tam, Y. Y. C.; Chen, S.; Hafez, I. M.; Cullis, P. R. Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems J. Phys. Chem. B 2015, 119, 8698-8706 10.1021/acs.jpcb.5b02891
106. Devine, D. V.; Wong, K.; Serrano, K.; Chonn, A.; Cullis, P. R. Liposome-Complement Interactions in Rat Serum: Implications for Liposome Survival Studies Biochim. Biophys. Acta, Biomembr. 1994, 1191, 43-51 10.1016/0005-2736(94)90231-3
107. Chonn, A.; Cullis, P. R.; Devine, D. V. The Role of Surface Charge in the Activation of the Classical and Alternative Pathways of Complement by Liposomes J. Immunol. 1991, 146, 4234-4241
108. Judge, A. D.; Sood, V.; Shaw, J. R.; Fang, D.; McClintock, K.; MacLachlan, I. Sequence-Dependent Stimulation of the Mammalian Innate Immune Response by Synthetic siRNA Nat. Biotechnol. 2005, 23, 457-462 10.1038/nbt1081
109. Hong, K.; Zheng, W.; Baker, A.; Papahadjopoulos, D. Stabilization of Cationic Liposome-Plasmid DNA Complexes by Polyamines and Poly(Ethylene Glycol)-Phospholipid Conjugates for Efficient In Vivo Gene Delivery FEBS Lett. 1997, 400, 233-237 10.1016/S0014-5793(96)01397-X
110. Zuckerman, J. E.; Davis, M. E. Clinical Experiences with Systemically Administered siRNA-Based Therapeutics in Cancer Nat. Rev. Drug Discovery 2015, 14, 843-856 10.1038/nrd4685